1. Home
  2. GRFS vs GGB Comparison

GRFS vs GGB Comparison

Compare GRFS & GGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.02

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Gerdau S.A.

GGB

Gerdau S.A.

HOLD

Current Price

$3.74

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
GGB
Founded
1940
1901
Country
Spain
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
7.1B
IPO Year
2006
1999

Fundamental Metrics

Financial Performance
Metric
GRFS
GGB
Price
$9.02
$3.74
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
$10.15
$4.60
AVG Volume (30 Days)
551.2K
11.9M
Earning Date
01-01-0001
10-30-2025
Dividend Yield
1.58%
2.73%
EPS Growth
N/A
N/A
EPS
0.64
0.28
Revenue
$8,821,017,248.00
$13,079,666,170.00
Revenue This Year
$5.36
$6.59
Revenue Next Year
$5.15
$2.59
P/E Ratio
$17.99
$12.43
Revenue Growth
7.31
7.37
52 Week Low
$6.19
$2.27
52 Week High
$11.14
$3.80

Technical Indicators

Market Signals
Indicator
GRFS
GGB
Relative Strength Index (RSI) 53.16 59.57
Support Level $8.69 $3.64
Resistance Level $9.22 $3.75
Average True Range (ATR) 0.18 0.09
MACD 0.03 0.00
Stochastic Oscillator 64.15 82.86

Price Performance

Historical Comparison
GRFS
GGB

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About GGB Gerdau S.A.

Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutors, mechanical construction bars, and reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives the majority of its revenue from the Brazil Operations segment.

Share on Social Networks: